Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis
YaLan Hu,
No information about this author
Kui Wang,
No information about this author
Yuhua Chen
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 10, 2024
Biliary
tract
cancer
stands
as
a
prevalent
illness,
posing
significant
risks
to
human
health,
where
immune
cells
are
pivotal
in
both
its
development
and
recovery
processes.
Due
the
diverse
functionalities
exhibited
by
different
cell
phenotypes
within
organism,
relatively
limited
research
on
their
relationship
with
biliary
cancer,
this
study
employed
Mendelian
randomization
(MR)
explore
potential
association,
thereby
aiding
better
understanding
of
causal
link
between
cancer.
Language: Английский
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo,
No information about this author
Xiaoyun Min,
No information about this author
Danying Zhang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 17, 2025
Osteosarcoma,
a
malignant
bone
tumor
primarily
affecting
adolescents,
is
highly
invasive
with
poor
prognosis.
While
surgery
and
chemotherapy
have
improved
survival
for
localized
cases,
pulmonary
metastasis
significantly
reduces
to
approximately
20%,
highlighting
the
need
novel
treatments.
Immunotherapy,
which
leverages
immune
system
target
osteosarcoma
cells,
shows
promise.
This
review
summarizes
biological
characteristics
of
osteosarcoma,
mechanisms
metastasis,
microenvironment
(TME).
It
involves
recent
immunotherapy
advances,
including
monoclonal
antibodies,
vaccines,
cell
therapies,
checkpoint
inhibitors,
oncolytic
viruses,
discusses
combining
these
standard
Language: Английский
Causal relationship between immune cells and risk of heart failure: evidence from a Mendelian randomization study
Wenjing Cao,
No information about this author
Zefu Yang,
No information about this author
Liumei Mo
No information about this author
et al.
Frontiers in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 23, 2025
Background
Heart
failure
(HF)
is
a
clinical
syndrome
resulting
from
structural
damage
or
dysfunction
of
the
heart.
Previous
investigations
have
highlighted
critical
involvement
immune
cells
in
progression
heart
failure,
with
distinct
roles
attributed
to
different
types
cells.
The
objective
current
research
was
explore
potential
connections
between
characteristics
and
development
HF,
as
well
ascertain
nature
causality
these
factors.
Methods
To
assess
causal
association
immunological
profiles
HF
based
on
publicly
available
genome-wide
studies,
we
employed
two-sample
Mendelian
randomization
technique,
utilizing
inverse
variance
weighted
(IVW)
method
our
primary
analytical
approach.
In
addition,
assessed
heterogeneity
cross-sectional
pleiotropy
through
sensitivity
analyses.
Results
A
(MR)
analysis
conducted
using
IVW
method.
At
significance
level
0.001,
identified
40
immunophenotypes
that
significant
relationship
HF.
There
phenotypes
failure.
These
immunophenotypes,
8
which
were
B
cells,
5
cDC,
2
T
cell
maturation
stage,
monocytes,
3
myeloid
7
TBNK
13
Treg.
Sensitivity
analyses
validate
strength
reliability
MR
findings.
Conclusions
Our
study
suggests
there
appears
be
effect
multiple
This
discovery
provides
new
avenue
for
therapeutic
treatments
target
drug
development.
Language: Английский
Causal Associations Between Immune Cell Phenotypes and Varicose Veins: A Mendelian Randomization Analysis
Sunqi Nian,
No information about this author
Kui Wang,
No information about this author
Jiawei Wang
No information about this author
et al.
Annals of Vascular Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Identification of lipid metabolism related immune markers in atherosclerosis through machine learning and experimental analysis
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 25, 2025
Atherosclerosis
is
a
significant
contributor
to
cardiovascular
disease,
and
conventional
diagnostic
methods
frequently
fall
short
in
the
timely
accurate
detection
of
early-stage
atherosclerosis.
Abnormal
lipid
metabolism
plays
critical
role
development
Consequently,
identification
new
markers
essential
for
precise
diagnosis
this
condition.
The
datasets
related
atherosclerosis
utilized
research
were
obtained
from
GEO
database
(GSE2470,
GSE24495,
GSE100927
GSE43292).
ssGSEA
technique
was
first
assess
scores
samples
affected
by
atherosclerosis,
thereby
aiding
discovery
important
regulatory
genes
linked
via
WGCNA.
Following
this,
differential
expression
analysis
functional
evaluations
carried
out,
after
which
various
machine
learning
approaches
employed
determine
A
model
then
developed
validated
through
several
algorithms.
Furthermore,
molecular
docking
studies
conducted
analyze
binding
affinity
these
key
with
therapeutic
agents
also
used
measure
immune
cell
atherosclerotic
samples,
exploration
connection
between
cells.
Finally,
variations
identified
pivotal
confirmed
experimental
validation.
WGCNA
302
metabolism-related
revealed
that
are
associated
multiple
pathways.
Through
further
screening
using
algorithms,
APLNR,
PCDH12,
PODXL,
SLC40A1,
TM4SF18,
TNFRSF25
as
we
constructed
predict
occurrence
high
accuracy,
indicated
six
have
potential
drug
targets.
Additionally,
algorithm
association
levels
experimentally
confirmed.
Our
study
introduces
novel
emphasizes
their
immune-related
This
provides
valuable
approach
predictive
targeted
therapy
Language: Английский
Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis
Wenzhe Hu,
No information about this author
Xudong Zhao,
No information about this author
Nan Luo
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 10, 2025
Background
Aberrant
hypermethylation
of
genomic
DNA
CpG
islands
(CGIs)
is
frequently
observed
in
human
pancreatic
cancer
(PAC).
A
plasma
cell-free
(cfDNA)
methylation
analysis
method
can
be
utilized
for
the
early
and
noninvasive
detection
PAC.
This
study
also
aimed
to
differentiate
PAC
from
other
types.
Methods
We
employed
methylated
tandem
amplification
sequencing
(MCTA-Seq)
method,
which
targets
approximately
one-third
CGIs,
on
samples
patients
(n
=
50)
healthy
controls
52),
as
well
cancerous
adjacent
noncancerous
tissue
66).
The
method’s
efficacy
detecting
distinguishing
it
hepatocellular
carcinoma
(HCC),
colorectal
(CRC),
gastric
(GC)
was
evaluated.
Additionally,
a
score
typing
system
established.
Results
identified
total
120
cfDNA
biomarkers,
including
IRX4
,
KCNS2
RIMS4
blood.
panel
comprising
these
biomarkers
achieved
sensitivity
97%
86%
discovery
validation
cohorts,
respectively,
with
specificity
100%
both
cohorts.
scoring
systems
were
clinically
applicable.
Furthermore,
we
hundreds
differentially
between
HCC,
CRC,
GC.
Certain
combinations
markers
used
highly
specific
(approximately
100%)
algorithm
GC
Conclusions
Our
PAC,
offering
novel
approach
early,
diagnosis
Language: Английский
Cholangiocarcinoma: The era of liquid biopsy
World Journal of Gastroenterology,
Journal Year:
2025,
Volume and Issue:
31(11)
Published: March 12, 2025
Cholangiocarcinoma
(CCA)
is
a
highly
aggressive
and
heterogeneous
malignancy
arising
from
the
epithelial
cells
of
biliary
tract.
The
limitations
current
methods
in
diagnosis
CCA
highlight
urgent
need
for
new,
accurate
tools
early
cancer
detection,
better
prognostication
patient
monitoring.
Liquid
biopsy
(LB)
modern
non-invasive
technique
comprising
diverse
group
methodologies
aiming
to
detect
tumour
biomarkers
body
fluids.
These
include
circulating
cells,
cell-free
DNA,
RNA
extracellular
vesicles.
aim
this
review
explore
potential
future
applications
LB
management,
with
focus
on
diagnosis,
We
examine
both
its
significant
inevitable
associated
technology.
conclude
that
holds
considerable
promise,
but
further
research
necessary
fully
integrate
it
into
precision
oncology
CCA.
Language: Английский
Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targets
Weihua Song,
No information about this author
Yabin Yu,
No information about this author
Shuai Wang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 21, 2025
Introduction
Pancreatic
adenocarcinoma
(PAAD)
is
characterized
by
a
profoundly
immunosuppressive
tumor
microenvironment
(TME)
that
limits
the
efficacy
of
immunotherapy.
Emerging
evidence
suggests
tumor-specific
metabolic
reprogramming
may
drive
disease
progression
and
shape
immune
landscape
in
PAAD.
Methods
We
integrated
multi-omics
data
from
TCGA,
GEO,
ICGC
to
identify
key
metabolism-related
genes
(MRGs)
influence
cell
infiltration,
progression,
patient
survival.
Based
on
nine
pivotal
MRGs
(including
ANLN,
PKMYT1,
HMGA1),
we
developed
validated
novel
metabolic-prognostic
index
(MPI).
Functional
enrichment
analyses
were
conducted
elucidate
pathways
associated
with
different
MPI
risk
groups.
In
vitro
experiments
drug
sensitivity
performed
confirm
oncogenic
role
selected
explore
their
therapeutic
implications.
Results
The
effectively
stratified
patients
into
high-
low-risk
High-MPI
scores
correlated
poor
overall
survival,
elevated
mutation
burden
(TMB),
an
TME,
evidenced
reduced
CD8⁺
T-cell
infiltration
increased
expression
checkpoints
(PD-L1,
TGF-β).
revealed
glycolysis
folate
biosynthesis
as
dominant
high-MPI
groups,
whereas
fatty
acid
metabolism
prevailed
low-MPI
Experimental
validation
underscored
ANLN
promoting
epithelial-mesenchymal
transition
(EMT)
evasion
via
NF-κB
signaling.
knockdown
significantly
glycolytic
activity,
migration,
evasion.
Drug
indicated
resistance
gemcitabine
but
afatinib
patients.
Although
TIDE
analysis
predicted
checkpoint
inhibitor
(ICI)
tumors,
subset
showed
favorable
responses
anti-PD-L1
therapy.
Discussion
These
findings
provide
comprehensive
framework
for
understanding
how
shapes
PAAD’s
TME
affects
treatment
outcomes.
By
accurately
stratifying
patients,
serves
promising
tool
guide
decisions,
including
targeted
therapy
selection
immunotherapy
prediction,
ultimately
offering
potential
more
personalized
management
Language: Английский
Causal relationship between immune cells and risk of myocardial infarction: evidence from a Mendelian randomization study
Frontiers in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Aug. 27, 2024
Background
Atherosclerotic
plaque
rupture
is
a
major
cause
of
heart
attack.
Previous
studies
have
shown
that
immune
cells
are
involved
in
the
development
atherosclerosis,
but
different
play
roles.
The
aim
this
study
was
to
investigate
causal
relationship
between
immunological
traits
and
myocardial
infarction
(MI).
Methods
To
assess
association
profiles
with
based
on
publicly
available
genome-wide
studies,
we
used
two-sample
mendelian
randomization
(MR)
approach
inverse
variance
weighted
(IVW)
as
main
analytical
method.
Sensitivity
analyses
were
heterogeneity
horizontal
pleiotropy.
Results
A
MR
analysis
conducted
using
IVW
primary
At
significance
level
0.001,
identified
47
immunophenotypes
significant
MI.
Seven
these
present
B
cells,
five
cDC,
four
T
at
maturation
stage,
six
monocytes,
myeloid
12
TBNK
eight
Treg
cells.
performed
confirm
robustness
results.
Conclusions
Our
results
provide
strong
evidence
multiple
effect
risk
infarction.
This
discovery
provides
new
avenue
for
therapeutic
treatments
target
drug
development.
Language: Английский